The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nanobiotechnology Market Research Report 2025
Synopsis
Nanobiotechnology is a veritable tool for the advancement of medical science, which will help improve healthcare practices across the world. This is because nanobiotechnology is the key for studying minute biological samples as small as a single molecule. The use of several nanoparticles and nanodevices for studying small biological samples are expected to benefit human health enormously. The use of nanobiotechnology is expected to extend opportunities and enhance the capabilities of other areas such as forensic science and forensic diagnostics.
The global Nanobiotechnology market was valued at US$ 67230 million in 2023 and is anticipated to reach US$ 103260 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Nanobiotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nanobiotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Nanobiotechnology in Anticancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Nanobiotechnology include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nanobiotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanobiotechnology.
Report Scope
The Nanobiotechnology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanobiotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanobiotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanobiotechnology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nanobiotechnology is a veritable tool for the advancement of medical science, which will help improve healthcare practices across the world. This is because nanobiotechnology is the key for studying minute biological samples as small as a single molecule. The use of several nanoparticles and nanodevices for studying small biological samples are expected to benefit human health enormously. The use of nanobiotechnology is expected to extend opportunities and enhance the capabilities of other areas such as forensic science and forensic diagnostics.
The global Nanobiotechnology market was valued at US$ 67230 million in 2023 and is anticipated to reach US$ 103260 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.
North American market for Nanobiotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nanobiotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Nanobiotechnology in Anticancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Nanobiotechnology include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nanobiotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanobiotechnology.
Report Scope
The Nanobiotechnology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nanobiotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nanobiotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
Segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanobiotechnology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanobiotechnology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nanomedicine
1.2.3 Nano Medical Devices
1.2.4 Nano Diagnosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nanobiotechnology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nanobiotechnology Market Perspective (2019-2030)
2.2 Nanobiotechnology Growth Trends by Region
2.2.1 Global Nanobiotechnology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Nanobiotechnology Historic Market Size by Region (2019-2024)
2.2.3 Nanobiotechnology Forecasted Market Size by Region (2025-2030)
2.3 Nanobiotechnology Market Dynamics
2.3.1 Nanobiotechnology Industry Trends
2.3.2 Nanobiotechnology Market Drivers
2.3.3 Nanobiotechnology Market Challenges
2.3.4 Nanobiotechnology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanobiotechnology Players by Revenue
3.1.1 Global Top Nanobiotechnology Players by Revenue (2019-2024)
3.1.2 Global Nanobiotechnology Revenue Market Share by Players (2019-2024)
3.2 Global Nanobiotechnology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanobiotechnology Revenue
3.4 Global Nanobiotechnology Market Concentration Ratio
3.4.1 Global Nanobiotechnology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanobiotechnology Revenue in 2023
3.5 Nanobiotechnology Key Players Head office and Area Served
3.6 Key Players Nanobiotechnology Product Solution and Service
3.7 Date of Enter into Nanobiotechnology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanobiotechnology Breakdown Data by Type
4.1 Global Nanobiotechnology Historic Market Size by Type (2019-2024)
4.2 Global Nanobiotechnology Forecasted Market Size by Type (2025-2030)
5 Nanobiotechnology Breakdown Data by Application
5.1 Global Nanobiotechnology Historic Market Size by Application (2019-2024)
5.2 Global Nanobiotechnology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Nanobiotechnology Market Size (2019-2030)
6.2 North America Nanobiotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Nanobiotechnology Market Size by Country (2019-2024)
6.4 North America Nanobiotechnology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nanobiotechnology Market Size (2019-2030)
7.2 Europe Nanobiotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Nanobiotechnology Market Size by Country (2019-2024)
7.4 Europe Nanobiotechnology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanobiotechnology Market Size (2019-2030)
8.2 Asia-Pacific Nanobiotechnology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Nanobiotechnology Market Size by Region (2019-2024)
8.4 Asia-Pacific Nanobiotechnology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nanobiotechnology Market Size (2019-2030)
9.2 Latin America Nanobiotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Nanobiotechnology Market Size by Country (2019-2024)
9.4 Latin America Nanobiotechnology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanobiotechnology Market Size (2019-2030)
10.2 Middle East & Africa Nanobiotechnology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Nanobiotechnology Market Size by Country (2019-2024)
10.4 Middle East & Africa Nanobiotechnology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Nanobiotechnology Introduction
11.1.4 Amgen Revenue in Nanobiotechnology Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Detail
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Nanobiotechnology Introduction
11.2.4 Teva Pharmaceuticals Revenue in Nanobiotechnology Business (2019-2024)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Nanobiotechnology Introduction
11.3.4 Abbott Revenue in Nanobiotechnology Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 UCB
11.4.1 UCB Company Detail
11.4.2 UCB Business Overview
11.4.3 UCB Nanobiotechnology Introduction
11.4.4 UCB Revenue in Nanobiotechnology Business (2019-2024)
11.4.5 UCB Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Nanobiotechnology Introduction
11.5.4 Roche Revenue in Nanobiotechnology Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Celgene
11.6.1 Celgene Company Detail
11.6.2 Celgene Business Overview
11.6.3 Celgene Nanobiotechnology Introduction
11.6.4 Celgene Revenue in Nanobiotechnology Business (2019-2024)
11.6.5 Celgene Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Nanobiotechnology Introduction
11.7.4 Sanofi Revenue in Nanobiotechnology Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 Merck & Co
11.8.1 Merck & Co Company Detail
11.8.2 Merck & Co Business Overview
11.8.3 Merck & Co Nanobiotechnology Introduction
11.8.4 Merck & Co Revenue in Nanobiotechnology Business (2019-2024)
11.8.5 Merck & Co Recent Development
11.9 Biogen
11.9.1 Biogen Company Detail
11.9.2 Biogen Business Overview
11.9.3 Biogen Nanobiotechnology Introduction
11.9.4 Biogen Revenue in Nanobiotechnology Business (2019-2024)
11.9.5 Biogen Recent Development
11.10 Stryker
11.10.1 Stryker Company Detail
11.10.2 Stryker Business Overview
11.10.3 Stryker Nanobiotechnology Introduction
11.10.4 Stryker Revenue in Nanobiotechnology Business (2019-2024)
11.10.5 Stryker Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Detail
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Nanobiotechnology Introduction
11.11.4 Gilead Sciences Revenue in Nanobiotechnology Business (2019-2024)
11.11.5 Gilead Sciences Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Nanobiotechnology Introduction
11.12.4 Pfizer Revenue in Nanobiotechnology Business (2019-2024)
11.12.5 Pfizer Recent Development
11.13 3M Company
11.13.1 3M Company Company Detail
11.13.2 3M Company Business Overview
11.13.3 3M Company Nanobiotechnology Introduction
11.13.4 3M Company Revenue in Nanobiotechnology Business (2019-2024)
11.13.5 3M Company Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Detail
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Nanobiotechnology Introduction
11.14.4 Johnson & Johnson Revenue in Nanobiotechnology Business (2019-2024)
11.14.5 Johnson & Johnson Recent Development
11.15 Smith & Nephew
11.15.1 Smith & Nephew Company Detail
11.15.2 Smith & Nephew Business Overview
11.15.3 Smith & Nephew Nanobiotechnology Introduction
11.15.4 Smith & Nephew Revenue in Nanobiotechnology Business (2019-2024)
11.15.5 Smith & Nephew Recent Development
11.16 Leadiant Biosciences
11.16.1 Leadiant Biosciences Company Detail
11.16.2 Leadiant Biosciences Business Overview
11.16.3 Leadiant Biosciences Nanobiotechnology Introduction
11.16.4 Leadiant Biosciences Revenue in Nanobiotechnology Business (2019-2024)
11.16.5 Leadiant Biosciences Recent Development
11.17 Kyowa Hakko Kirin
11.17.1 Kyowa Hakko Kirin Company Detail
11.17.2 Kyowa Hakko Kirin Business Overview
11.17.3 Kyowa Hakko Kirin Nanobiotechnology Introduction
11.17.4 Kyowa Hakko Kirin Revenue in Nanobiotechnology Business (2019-2024)
11.17.5 Kyowa Hakko Kirin Recent Development
11.18 Shire
11.18.1 Shire Company Detail
11.18.2 Shire Business Overview
11.18.3 Shire Nanobiotechnology Introduction
11.18.4 Shire Revenue in Nanobiotechnology Business (2019-2024)
11.18.5 Shire Recent Development
11.19 Ipsen
11.19.1 Ipsen Company Detail
11.19.2 Ipsen Business Overview
11.19.3 Ipsen Nanobiotechnology Introduction
11.19.4 Ipsen Revenue in Nanobiotechnology Business (2019-2024)
11.19.5 Ipsen Recent Development
11.20 Endo International
11.20.1 Endo International Company Detail
11.20.2 Endo International Business Overview
11.20.3 Endo International Nanobiotechnology Introduction
11.20.4 Endo International Revenue in Nanobiotechnology Business (2019-2024)
11.20.5 Endo International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
